Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

DIRECTORS' DEALING

17 Apr 2015 07:00

RNS Number : 4998K
Plant Health Care PLC
17 April 2015
 

 



Plant Health Care plc

Friday, 17 April 2015

 

PLANT HEALTH CARE plc (THE "COMPANY")

DIRECTORS' DEALING

The Company today announces that, on 16 April 2015, a total of 25,880 ordinary shares of 1p ("Ordinary Shares") were allotted to Paul Schmidt, Chief Executive Officer, in satisfaction of a half share of his (net) cash bonus for 2014. The quantum of shares allotted was based on the closing middle market price of 111.5p derived from the Daily Official List on 15 April 2015 and the exchange rate of $1: £0.68012 prevailing at that time.

Application has been made for 25,880 Ordinary Shares (the 'New Shares') to be admitted to trading on the London Stock Exchange's AIM market for listed securities ("Admission") and admission is expected to occur on 27 April 2015. The New Shares will rank pari passu with the Company's existing Ordinary Shares.

The Company today further announces that, on 16 April 2015, options over a total of 89,686 Ordinary Shares were granted to William ("Bill") M. Lewis, a non-executive director, in accordance with the terms of a share option agreement under which Bill Lewis is to be granted Ordinary Shares in the Company to the value of £100,000, exercisable (not earlier than three years from the date of his appointment) at the price per share prevailing at the date of grant (111.5p), consequent upon his appointment as a non-executive director of the Company.

Following the above-mentioned allotments of Ordinary Shares and grant of options, Paul Schmidt and Bill Lewis's beneficial interests in the enlarged Ordinary Share capital of the Company are as shown below:

 Name

Ordinary Share holding

Percentage of enlarged Ordinary Share capital

Share Options

Value Creation Plan

Paul Schmidt

82,880

0.12%

200,000

1,709,821

William Lewis

 

NIL

N/A

89,686

N/A

 

Application has been made for 7,500 Ordinary Shares to be admitted to trading on the London Stock Exchange's AIM market for listed securities. The new Ordinary Shares ("New Shares") are being issued pursuant to the acceptance of an exchange offer for minority shares formerly held in Plant Health Care, Inc. Admission is expected to become effective on 27 April 2015. The New Shares will rank pari passu with the Company's existing Ordinary Shares.

 

Following admission of these Ordinary Shares, the total issued share capital of the Company will be 71,743,085 Ordinary Shares, all of which have voting rights. There are no shares in treasury.

 

The above figure (71,743,085 Ordinary Shares) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

-: Ends :-

Enquiries:

Plant Health Care plcDr. Christopher Richards, Executive ChairmanTel: +44 (0)1837 880083ir@planthealthcare.com 

Liberum Capital - Nomad and Broker

Clayton Bush

Tel: +44 (0) 20 3100 2000

 

LHAEd McGregor / Jody BurfeningTel: +1 (212) 8383777

Company website: www.planthealthcare.com

 About Plant Health Care: Plant Health Care is a leading provider of novel patent-protected biological products to the global agriculture markets. Through the commercialisation of these products, Plant Health Care is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. The Company's ordinary shares have been quoted on the AIM market of the London Stock Exchange since July 2004 (ticker symbol: PHC).

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSDQLFFEZFLBBQ
Date   Source Headline
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments
12th Jan 20237:00 amRNSNovozymes Distribution Agreement
9th Jan 20237:00 amRNSInvestor Presentation
22nd Dec 20227:00 amRNSNew Products Submitted for Regulatory Approval
28th Oct 20227:00 amRNSRegistration of Harpin in France
28th Oct 20227:00 amRNSNew distribution agreement with EDAF
27th Oct 20227:00 amRNSTrading Update
14th Oct 20225:11 pmRNSDirector/PDMR Shareholding
14th Oct 202210:39 amRNSDirector / PDMR Shareholding
26th Sep 20227:00 amRNSInterim Results
22nd Aug 20227:00 amRNSTrials agreement signed with Agrii UK
12th Aug 20227:00 amRNSGrant of Options
10th Aug 20225:04 pmRNSDirector/PDMR Shareholding
21st Jul 20222:41 pmRNSHolding(s) in Company
18th Jul 20227:02 amRNSInvestor Presentation
18th Jul 20227:00 amRNSPost-Close Trading Update
22nd Jun 202212:37 pmRNSResult of AGM
21st Jun 20227:00 amRNSCompletion of Nominated Adviser due diligence
20th Jun 20227:00 amRNSLong-term Harpin Production and Supply Agreement
6th Jun 20228:00 amRNSHolding(s) in Company
6th Jun 20228:00 amRNSHolding(s) in Company
1st Jun 20222:31 pmRNSDirector/PDMR Shareholding
25th May 20225:23 pmRNSHolding(s) in Company
23rd May 20227:30 amRNSAnnual Report & Accounts and Notice of AGM
23rd May 20227:00 amRNSNew distribution agreement with Nutrien
16th May 20227:00 amRNSHolding(s) in Company
12th May 20227:15 amRNSCEO appointment and Board changes
12th May 20227:00 amRNSResults for the year ended 31 December 2021
28th Apr 20227:00 amRNSChange of Adviser
21st Apr 20222:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.